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The lower esophageal sphincter (LES) is a specialized region of the esophageal smooth muscle that allows
the passage of a swallowed bolus into the stomach. Nitric oxide (NO) plays a major role in LES relaxation.
Nicorandil possesses dual properties of a NO donor and an ATP-sensitive potassium channel (KATP channel)
agonist, and is expected to reduce LES tone. This study investigated themechanisms underlying the effects
of nicorandil on the LES. Rat LES tissueswere placed in an organ bath, and activities were recorded using an
isometric force transducer. Carbachol-induced LES contraction was signiﬁcantly inhibited by KATP channel
agonists in a concentration-dependent manner; pinacidil >> nicorandilz diazoxide. Nicorandil-induced
relaxation of the LES was prevented by pretreatment with glibenclamide, whereas NG-nitro-L-arginine
methyl ester (L-NAME), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and iberiotoxin were ineffec-
tive at preventing nicorandil-induced LES relaxation. Furthermore, nicorandil did not affect high Kþ-
induced LES contraction. Reverse-transcription polymerase chain reaction analysis and immunohisto-
chemistry revealed expression of KCNJ8 (Kir6.1), KCNJ11 (Kir6.2), ABCC8 (SUR1) and ABCC9 (SUR2) subunits
of the KATP channel in the rat lower esophagus. Theseﬁndings indicate that nicorandil causes LES relaxation
chieﬂy by activating the KATP channel, and that it may provide an additional pharmacological tool for the
treatment of spastic esophageal motility disorders.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
The lower esophageal sphincter (LES) is a specialized region of
the esophageal circular smooth muscle at the junction between the
esophagus and the stomach. It allows the passage of a swallowed
bolus into the stomach while preventing the reﬂux of gastric con-
tents into the esophagus (1e4). The LES is composed of at least two
separate muscle components, the circular and the oblique sling
muscles. Two muscles are functionally different; the sling muscle
has little intrinsic myogenic tone but contracts vigorously to
cholinergic stimulation, and the circularmuscle is characterizedbya
spontaneously generated basal tone that helps to prevent reﬂux of
gastric contents into the esophagus. The basal tone of the LES is
primarilymyogenic andcanbemodulatedbyentericmotorneurons,
the parasympathetic and sympathetic extrinsic nervous system andrmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).several neurohumoral substances (3). Dysfunction of LES motility is
an important factor in the pathogenesis of gastroesophageal reﬂux
disease, esophageal dysmotility and esophageal hypersensitivity
(5e7). Such disorders often cause recurrent, angina-like, retro-
sternal chest pain. After excluding a cardiac cause, they are treated
with medical, endoscopic and surgical therapeutics (6).
Nitric oxide (NO), synthesized by neuronal nitric oxide synthase
(NOS), is the main inhibitory neurotransmitter involved in LES
relaxation (1,3,8,9). NO is also synthesized in smooth muscles cells
by a spontaneously active constitutive NOS, called myogenic NOS,
and contributes to the restingmembrane potential and tone (10,11).
It is generally accepted that NO activates the large conductance Kþ
channel (BKCa) and causes membrane hyperpolarization. This
mechanism potentially leads to LES relaxation (11e15). Exogenous
NO is also able to cause LES relaxation, and therefore, spasticmotility
disordersof theesophagus canbe treatedwithnitrate aswell asCa2þ
channel blockers and phosphodiesterase type 5 inhibitors (6).
Nicorandil possesses dual properties as an NO donor and an
ATP-sensitive potassium channel (KATP channel) agonist, and isnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
T. Shimbo et al. / Journal of Pharmacological Sciences 131 (2016) 267e274268widely used as an anti-angina drug. KATP channels composed of
inward-rectifying potassium channel subunits (Kir6.1 and Kir6.2,
encoded by KCNJ8 and KCNJ11, respectively) and regulatory sulfo-
nylurea receptor (SUR1 and SUR2, encoded by ABCC8 and ABCC9,
respectively). Alternative RNA splicing can give rise tomultiple SUR
protein variants (e.g., SUR2A and SUR2B) that confer distinct
physiological and pharmacological properties on the channel
complex (16e22). The drug activates KATP channels and relaxes not
only vascular smooth muscles but also smooth muscles of other
tissues, including those of the uterus, airway, anal sphincter,
stomach, and ureter (16e22). It is therefore possible that nicorandil
reduces LES contraction by dual mechanisms. The aim of this study
was to elucidate the mechanisms underlying the effects of nicor-
andil on LES tone in the rat.
2. Materials and methods
2.1. Measurement of LES tension
All animal experiments were approved by The Animal Ethics
Committee of Akita University School of Medicine (No. a-1-2601).
Fifty eight male Wister rats weighing 230e520 g were used in this
study. After inducing anesthesia with intraperitoneal injection of
thiopental sodium (50mg/kg), an incisionwas made to open up the
abdominal and thoracic cavities, and the esophagus including the
LES was excised. Excess fat and connective tissue were dissected
and the LES was set up as a ring segment of 3 mm inwidth. The LES
ring preparation was placed in a standard organ bath ﬁlled with
normal Tyrode's solution. The LES ring was tied to a stainless steel
hook at one end of the organ bath, and the other endwas connected
to a force transducer. LES ring activities were recorded on an online
computer using Chart Pro V 4.0 (AD Instruments, New Zealand).
The chamber was continuously gassed with 100% O2 and main-
tained at 35 C. The LES ring preparationwas gently stretched up to
1 g, and a stable tone was achieved after an equilibration period of
approximately 1 h.
2.2. Solutions and drugs
The composition of the normal Tyrode's solution contained
(mM) NaCl 136.9, KCl 5.4, CaCl2 1.8, MgCl2 0.5, NaH2PO4 0.33, HEPES
5.0, and glucose 5.5 (pH 7.4, adjusted with NaOH). The high-Kþ
Tyrode's solution contained (mM) NaCl 92.3, KCl 50, CaCl2 1.8,
MgCl2 0.5, NaH2PO4 0.33, HEPES 5.0, and glucose 5.5 (pH 7.4,
adjusted with NaOH).10
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Fig. 1. Concentration-dependent contraction of the rat LES by carbachol. A: A representative r
the organ bath so as to obtain the concentration (in mM) described above the recording. The d
The smooth curve represents the least squares ﬁt of the data to the Hill equation with a half-Carbachol chloride, nicorandil, iberiotoxin (IbTX), nifedipine,
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and sodium
nitroprusside (SNP) were purchased from Wako Pure Chemical Co.
(Osaka, Japan). Glibenclamide was purchased from Funakoshi Co.
(Tokyo, Japan). NG-nitro-L-arginine methyl ester, hydrochloride (L-
NAME), diazoxide, charybdotoxin (ChTX) and pinacidil were pur-
chased from SigmaeAldrich Co. (St. Louis, MO, USA). Nicorandil was
dissolved in ethanol as a 10 mM stock solution and diluted in the
bath solution to give each concentration described in the text.
Nifedipine, glibenclamide and pinacidil were dissolved in dimethyl
sulfoxide as 10 mM stock solutions. Carbachol, L-NAME, IbTX, ChTX,
ODQ, diazoxide and SNP were dissolved in distilled water and
diluted in the bath solution.
2.3. Data analysis and statistics
Following incubation in normal Tyrode's solution for more than
1 h, the LES rings were subjected to various drugs, as described in
the text. The concentrationeresponse relationship for carbachol
was obtained by cumulatively adding carbachol to the organ bath
(Fig. 1). The amplitude of the response was measured and
normalized with reference to the maximum response. The rela-
tionship between the carbachol concentration and the magnitude
of the increase in the tension was ﬁtted with Hill's equation,
F/Fmax ¼ 1/(1 þ (EC50/[D])n),
where EC50 is the half maximal-effective concentration of carbachol
and n is the Hill coefﬁcient. In the experiments where the con-
centrationeresponse relationships for various KATP channel
openers (Fig. 2B) and SNP (Fig. 4) were examined, the magnitude of
the inhibition was normalized with reference to the response to
1 mM carbachol. The relationships were ﬁtted to Hill's equation,
except that half-maximal inhibitory concentration (IC50) values
were obtained instead of EC50 values.
Results are expressed as the mean ± SEM. Signiﬁcant differences
between drug treatments were determined by analysis of variance,
and a P value <0.01 was considered statistically signiﬁcant.
2.4. Reverse-transcription polymerase chain reaction (RT-PCR)
analysis
RT-PCR was used to conﬁrm the expression level of pore-
forming and regulatory subunits in the esophageal KATP channel.
Esophageal tissues taken from each part of the esophagus (upper,B
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Fig. 2. Inhibition of the carbachol-contracted LES by KATP channel openers. A: Representative recordings for the effects of KATP channel openers on the carbachol-contracted LES are
shown. After obtaining a stable response to 1 mM carbachol, nicorandil (a), diazoxide (b) and pinacidil (c) were cumulatively applied to the organ bath at times indicated by the
arrow heads. The numbers indicate the concentration of the drug in mM. The dashed lines indicate the basal tension level. B: Concentrationeresponse relationships for nicorandil
(ﬁlled circles), diazoxide (open circles) and pinacidil (open squares). Smooth curves were drawn from the least squares ﬁt of the data to the Hill equation with a half-saturation
concentration of 37.4 mM for nicorandil, 83.8 mM for diazoxide, and 1.25 mM for pinacidil. Data are means ± SEM of 10 experiments.
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using Isogen II (Nippon Gene, Tokyo, Japan), and 1 mg RNA was
reverse-transcribed using an oligo dT primer in a ﬁnal volume of
20 mL. Sequences of primers are as follows: for KCNJ8 (Kir6.1), for-
ward, 50-CCGTCTGTGTGACCAATGTC-30, reverse, 50-CGTGGTTTT
CTTGACCACCT-30, 350 bp was the size of the PCR product; for
KCNJ11 (Kir6.2), forward, 50-CCTGGCCATCCTTATTCTGA-30, reverse,
50-TTGGAGTCGATGACGTGGTA-30, 363 bp was the size of the PCR
product; for ABCC8 (SUR1), forward, 50-CCTGCAGCCAGACATA-
GACA-30, reverse, 50-CAGTCAGCATGAGGCAGGTA-30, 276 bp was the
size of the PCR product; for ABCC9 (SUR2), forward 50-GGAGC-
CAAAGCTCAAAAGTG-30, reverse, 50-AGAAGCGCAGGTCTGACATT-30,
354 bp was the size of the PCR product. In the present study, the
primer pairs for SUR2 were constructed based on the common
regions of both SUR2A and SUR2B, and therefore do not discrimi-
nate them.
2.5. Immunohistochemistry
Esophagus including LES was ﬁxed with 4% paraformaldehyde,
embedded in parafﬁn, and sectioned 4 mm-thick slices longitudi-
nally. Sections were deparafﬁnized by incubation in xylene (three
times by 10 min), followed by washing and rehydration in ethanol
(three times by 5 min). Sections were processed by phosphate-
buffered saline (PBS) plus 0.1% TritonX100 for increased mem-
brane permeability. The sections were then washed with PBS and
blocked with 3% (w/v) bovine serum albumin in PBS at room tem-
perature for 10min. In order to detect the histological localization of
Kir6.1 and SUR2 proteins, the LES sectionswere next incubatedwith
a goat anti-Kir6.1 primary antibody (NPB1-70370, NOVUS BI-
OLOGICALSMinneapolis,USA;diluted1:300) anda rabbit anti-SUR2
primary antibody (LS-C119322, LifeSpan BioSciences, Inc; diluted
1:100) in blocking solution at room temperature for 3 h. Following
washing with PBS (3 times for 5 min), sections were incubated withAlexa Fluor 594 donkey anti-rabbit IgG (A-21207, Invitrogen Carls-
bad, CA, USA; diluted 1:100) and Alexa Fluor 488 donkey anti-goat
IgG (ab150129, Abcam; diluted 1:200) in blocking solution for
20 min at room temperature in the dark. In order to detect the
localizationofKir6.2 andSUR1proteins, the sectionswere incubated
with a goat anti-Kir6.2 primaryantibody (orb19764, Biorbyt Ltd, UK;
diluted 1:100) and a rabbit anti-SUR1 primary antibody (orb7031,
Biorbyt Ltd, UK; diluted 1:100) in the blocking solution at room
temperature for 3 h. Followingwashingwith PBS (3 times for 5min),
sections were incubated with the secondary antibodies. After
further rinse with PBS, the sections were incubated for 5 min with
DAPI (40,6-diamidino-2-phenylindole, dihydrochloride, Vector Lab-
oratories Inc, BurlingameCA,USA) for nuclear staining. Fluorescence
images of stained LES were obtained using a confocal microscope
(Zeiss 510, Zeiss, Oberkochen, Germany).
3. Results
3.1. Inhibition of the carbachol-contracted LES by KATP channel
openers
We ﬁrst examined carbachol concentration-dependent LES
contraction. A representative trace is shown in Fig. 1A, where
carbachol was cumulatively added to the organ bath, resulting in an
increase of LES tension. The carbachol concentration-relationship
was obtained for 10 preparations and is illustrated in Fig. 1B. The
smooth curve was drawn using the least squares ﬁt to the Hill
equation, and the EC50 of carbachol was 1.12 ± 0.13 mM. The Hill
coefﬁcient was 1.47 ± 0.02.
The effects of various KATP channel openers on the carbachol-
contracted LES are illustrated in Fig. 2. After obtaining a stable
response to 1 mM carbachol, KATP channel openers were cumula-
tively applied to the organ bath. It was evident that all KATP channel
openers inhibited the carbachol-contracted LES in a concentration-
T. Shimbo et al. / Journal of Pharmacological Sciences 131 (2016) 267e274270dependent manner. The concentrationeresponse relationships
shown in Fig. 2B revealed IC50 values of 41.2 ± 7.1 mM (n ¼ 4) for
nicorandil, 68.0 ± 8.8 mM (n ¼ 4) for diazoxide, and 1.19 ± 0.18 mM
(n ¼ 4) for pinacidil. The Hill coefﬁcient was 1.42 ± 0.20 for nicor-
andil, 1.16 ± 0.13 for diazoxide and 1.43 ± 0.44 for pinacidil.
3.2. Possible contribution of KATP channels and NO to the inhibitory
action of nicorandil
The inhibitory effects of nicorandil on the carbachol-contracted
LES were examined in the presence of various substances. Gliben-
clamide, a KATP channel inhibitor, successfully prevented the
inhibitory effect of nicorandil (Fig. 3Aa). On the other hand, L-
NAME, an NOS inhibitor or ODQ, a guanylate cyclase inhibitor, did
not affect the nicorandil effect (Fig. 3Abc). We also examined a
possible contribution of the high-conductance Ca2þ-activated Kþ
channels (BKCa) using IbTX. However, IbTX failed to attenuate the
inhibitory effect of nicorandil on the carbachol-contracted LES.
From 47 preparations, 100 mM nicorandil alone inhibited the
carbachol (1 mM)-induced contraction by an average of 59.9 ± 3.2%;
this was signiﬁcantly reduced to 29.9 ± 2.1% in the presence of
10 mM glibenclamide (n¼ 25, P < 0.01). Although the concentration
of glibenclamide was increased up 100 mM, no further inhibition
was observed (32.3 ± 3.9%, n ¼ 19; P < 0.01 vs nicorandil alone). On
the other hand, the inhibition was 52.3 ± 3.2% (n ¼ 29), 45.4 ± 3.6%
(n ¼ 9), and 56.1 ± 6.2% (n ¼ 7) in the presence of 100 mM L-NAME,
10 mM ODQ and 0.1 mM IbTX, respectively, and no signiﬁcant dif-
ference was observed when compared with the control (100 mM
nicorandil alone).
3.3. Inhibition of the carbachol-contracted LES by NO
To examine the effect of NO on the carbachol-contracted LES,
SNP, an NO donor, was applied in the presence of 1 mM carbachol.
SNP effectively inhibited the carbachol-contracted LES in a
concentration-dependent manner (Fig. 4Ba). Fig. 4A shows theCCh
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Fig. 3. Inhibitory effects of nicorandil on the carbachol-contracted LES in the presence o
nicorandil on the carbachol-contracted LES in the presence of various blockers. In the presen
the effect of nicorandil on the carbachol-contracted LES was examined using the protocol
carbachol 1 mM. The dashed lines indicate the basal tension levels. B: The inhibitory effect of
mean with SEM. *P < 0.01 vs control (1 mM carbachol þ 100 mM nicorandil).concentrationeresponse relationship for SNP, with an IC50 value of
1.86 ± 0.11 mM and a Hill coefﬁcient of 0.93 ± 0.08 (n ¼ 5). This
inhibitory effect of SNP was attenuated by 10 mM ODQ (Fig 4Bb). A
potential mechanism leading to LES relaxation is NO activation of
BKCa causing membrane hyperpolarization (11e15). However, the
inhibitory effect of SNP on the carbachol-contracted LES was not
affected by 0.1 mM IbTX (Fig 4Bc), a highly selective and potent
blocker of the BKCa, or by 0.1 mM ChTX (Fig 4Bd), a blocker of BKCa
and intermediate conductance Ca2þ-activated Kþ channels. On
average, 1 mM SNP alone inhibited the carbachol-contracted LES by
76.9 ± 3.2% (n ¼ 14). This was signiﬁcantly decreased to 21.7 ± 5.6%
(n ¼ 6) by 10 mM ODQ (P < 0.01). No signiﬁcant difference was
observed depending on whether or not the LES was pre-incubated
with 0.1 mM IbTX (79.6 ± 4.1%, n ¼ 6) or 0.1 mM ChTX (86.3 ± 2.7%,
n ¼ 2).
3.4. Effect of nicorandil on high Kþ concentration-induced LES
contraction
In the experiment shown in Fig. 5A, the LES was contracted by
increasing the Kþ concentration of the bath solution from 5.4 to
50 mM and the effect of nicorandil was then examined. Neither
nicorandil nor SNP affected high Kþ concentration-induced LES
contraction, whereas 1 mM nifedipine signiﬁcantly attenuated the
response. On average, the inhibition was 1.3 ± 1.9% (n ¼ 4) for
100 mMnicorandil, 0.7 ± 1.8% (n¼ 5) for 10 mM SNP, and 57.1 ± 4.6%,
(n ¼ 4) for 1 mM nifedipine. These ﬁndings are consistent with the
view that high Kþ concentration-induced LES contraction is due to
the depolarization of LESmuscles leading to the activation of L-type
Ca2þ channels (23). Also, the ﬁndings suggest that the inhibitory
effects of nicorandil and SNP are caused by Kþ channel activation.
3.5. Expression of pore-forming and regulatory subunits in the LES
Using RT-PCR, themRNA levels of KCNJ8 (Kir6.1), KCNJ11 (Kir6.2),
ABCC8 (SUR1) and ABCC9 (SUR2B) were determined in the upper,10 
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times indicated by the arrow heads. The numbers indicate the concentrations of SNP in mM. The inhibitory effects of SNP were examined in the presence of 10 mM ODQ (b), 0.1 mM
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(Fig. 6). Distinct amplicons of the expected sizes were detected for
KCNJ8 (Kir6.1) and KCNJ11 (Kir6.2) in all parts of the esophagus. The
primer pairs designed to recognize ABCC8 (SUR1) generated strong
bands in the upper and lower parts of the esophagus, and the
primer pairs for ABCC9 (SUR2B) produced relatively weak bands,
particularly in the upper part of the esophagus. Similar results were
obtained in all PCR assays performed on mRNA extracted from four
preparations.
Fig. 7 shows longitudinal sections of the LES. Red and green
color in these images represents SURx and Kir6.x, respectively, and
DAPI was used for nuclear staining. Both the circular and oblique
sling muscle layers were stained with SURx and Kir6.x, and there
were no obvious gradient in the expression pattern of circular and
longitudinal muscle layers. Similar results were obtained in two
other preparations.
4. Discussion
The present study demonstrated that nicorandil inhibited the
contractile response to carbachol in rat LES ring preparations in a
concentration-dependent manner, and that this effect was pre-
vented, although not completely, by glibenclamide. Inhibition of
the carbachol-contracted LES was also observed for other KATP
channel openers, pinacidil and diazoxide.We also showed that SNP,
an NO donor, could inhibit the carbachol-contracted LES, an effect
that was suppressed by ODQ. On the other hand, neither ODQ nor L-
NAME prevented the nicorandil effect. Furthermore, nicorandil
failed to affect LES tension when the LES was contracted by a high
concentration Kþ-solution. These ﬁndings suggest that the relaxing
effect of nicorandil on the LES rings is mainly caused by KATP
channel activation, and that the contribution of NO might be rela-
tively small. This is the ﬁrst study to demonstrate that nicorandil
has a relaxing effect on the isolated LES.
KATP channels are widely distributed among various types of
excitable cells, where their primary function is to couplemembrane
excitability to cellular energy levels (22). KATP channels in different
tissues are made up of different pore-forming and regulatory sub-
units. In most tissues, KCNJ11 (Kir6.2) acts as the pore-forming
subunit, although in some smooth muscles KCNJ8 (Kir6.1) serves
this role. KATP channel openers stimulate KATP channel activity
primarily by binding to the regulatory subunit, and native KATP
channels fromdifferent tissues display different sensitivities to KATP
channel openers. The differential tissue sensitivity to KATP channel
openers can be attributed to the different types of regulatoryFig. 6. Expression of pore-forming and regulatory subunits of KATP channels in the rat
esophagus. Comparative reverse-transcription polymerase chain reaction (RT-PCR)
analysis of gene expression for KCNJ11 (Kir6.2), KCNJ8 (Kir6.1), ABCC8 (SUR1) and
ABCC9 (SUR2B) in upper esophagus, middle esophagus and LES. Consistent results
were obtained for each experiment repeated four or more times.subunits that make up b-cell (SUR1), cardiac (SUR2A) and smooth
muscle (SUR2B) KATP channels (22). Pancreatic b-cell KATP channels
are readily activated by diazoxide, weakly activated by pinacidil,
and unaffected by cromakalim or nicorandil. Cardiac KATP channels
are activated by pinacidil, cromakalim, and nicorandil but not by
diazoxide. The smooth muscle KATP channel is activated by all of
these drugs (22). In the present study, KATP channel openers
inhibited the carbachol-contracted LES with the potency:
pinacidil >> nicorandil z diazoxide. These ﬁndings suggest that
nicorandil has a relaxing effect on LES smooth muscle by activating
KATP channels that contain SUR2B. Consistently, RT-PCR analysis
and immunohistochemistry conﬁrmed the existence of KCNJ8
(Kir6.1), KCNJ11 (Kir6.2), ABCC8 (SUR1) and ABCC9 (SUR2) in the
LES, although discrimination of SUR2A and SUR2B was not per-
formed in the present study.
It has been reported that there is heterogeneity of KATP expres-
sion in a variety of visceral smoothmuscle tissues (24). For example,
urethral myocytes express the Kir6.2 and SUR1 isoforms in addition
to Kir6.1 and SUR2B (25), and heteromeric assembly of Kir6.1 with
the Kir6.2 in a (Kir6.1)3-(Kir6.2)1 arrangement with intermediate
channel behavior was suggested (24). Colonic smooth muscle ex-
presses Kir6.2 and SUR2B mRNA with no evidence for Kir6.1 tran-
script expression (26). Functional characteristics of KATP channels are
also variable, with the predominant nonvascular KATP subtype
recapitulating the salient properties of the KATP channel, including a
low unitary conductance (40 pS), a requirement for nucleoside di-
phosphates for activation, and similar sensitivity to KATP channel
openers. In this respect, it is interesting to know electrophysiological
properties of KATP channels of the rat LES. Further studieswith a help
of electrophysiological techniques are clearly necessary to obtain
functional evidence of KATP channels in the LES.
Irrespective of the above heterogeneities, the activation of KATP
channels is expected to drive the membrane potential toward the
equilibrium potential for Kþ (19). It has been reported that LES
myocytes are more depolarized than those of the esophageal body,
displaying a less negative resting membrane potential with rela-
tively high Cl conductance (3,27,28). The relatively depolarized
resting state of themuscle creates sphincteric tone and favors to the
occurrence of spontaneous spike-like action potentials. Cl
conductance suppression or activation of Kþ conductance may
inhibit continuous spike activity and hyperpolarize the cell mem-
brane (28). Thus, activation of KATP channels would hyperpolarize
the cell membrane to prevent Ca2þ entry through voltage-
dependent Ca2þ channels, thereby leading to relaxation of LES
myocytes.
Glibenclamide suppressed the 10 mM nicorandil effect by
approximately 30%, and the extent was unchanged even if the
concentration of glibenclamide was increased up to 100 mM. This
ﬁnding may indicate the existence of mechanisms other than KATP
channel activation. It is generally accepted that NO is the main
neurotransmitter for active inhibition and relaxation of the LES
(9,29), and the primary mechanism for NO-mediated relaxation is
considered to be via a cGMP pathway. In the present study, how-
ever, the carbachol-contracted LES was not affected by ODQ or L-
NAME. It seems that an NO-dependent mechanism is not involved
in the nicorandil effect on the LES contraction.
On the other hand, an externally applied NO donor, SNP, mark-
edly suppressed the carbachol-contracted LES, and this effect was
signiﬁcantly attenuated by ODQ. This ﬁnding is consistent with the
view that NO is the main neurotransmitter for active inhibition and
relaxation of the LES (9,29). There are several potential intracellular
pathways whereby NO can lead to smooth muscle relaxation.
Involvement of BKCa has been demonstrated in various species
including cat (12), opossum (13), guinea pig (15), dog (10) and
mouse (30). The activation of BKCa causes membrane
Fig. 7. Images of longitudinal sections of LES showing ﬂuorescent labeling of immunoreactivity for SURx and Kir6.x. A: Immunoreactivity detected with anti-SUR1 antibody (a) and
anti-Kir6.2 antibody (b), DAPI nucleic acid stain (c) and an overlay of panels a, b and c (d). Bars (white lines) represent 50 mm. B: Immunoreactivity detected with anti-SUR2 antibody
(a) and anti-Kir6.1 antibody (b), DAPI nucleic acid stain (c) and an overlay of panels a, b and c (d). Bars (white lines) represent 50 mm.
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study, there were conﬂicting ﬁndings regarding this point. On one
hand, blockers of BKCa, IbTX and ChTX, were ineffective at sup-
pressing the effect of SNP on the carbachol-contracted LES (Fig. 4).
On the other hand, SNP failed to attenuate the high Kþ-contracted
LES (Fig. 5). The former suggests that BKCa is unlikely to be involved
in the SNP effect, whereas the latter favors Kþ channels mediating
the underlying mechanism. We speculate that Kþ channels, which
are insensitive to IbTX and ChTX, might have been activated by NO.
The responses and the underlying mechanism seem to be different
depending on species, the type of muscle, i.e., circular or sling, and
on the source of NO. In the canine LES, multiple Kþ channels have
been reported to open in response to NO derived from muscle, and
NO donors act partly by opening Kþ channels and partly by other
mechanisms (11). In the opossum LES, a decrease in Cl current and
BKCa activationwere observed in response to external application of
the NO donor, S-nitroso-L-cysteine (13). Furthermore, L'Heureux
et al. reported that exogenous NO-induced relaxation occurred
predominantly by a non-BKCa mechanism in the cat (12); SNP
activated the IbTX-sensitive outward current only in circular mus-
cle cells, and SNP reduced tone in both circular and sling muscles,
and was unaffected by IbTX (12).
The LES is an important specialized smooth muscle in the
gastrointestinal tract, and its dysfunction is thought to underlie
various diseases such as achalasia and gastroesophageal reﬂux
disease (5e7). It is well known that non-cardiac chest pain is a
common condition deﬁned as recurring, angina-like, retrosternal
chest pain of non-cardiac origin. There are many potential etiol-
ogies for non-cardiac chest pain, but the esophagus appears to be
the most common source for this symptom. The therapeutic op-
tions for non-cardiac chest pain patients with esophageal dysmo-
tility, including esophageal spasm, hypercontracting esophagus and
hypertensive LES, include medical, endoscopic and surgical treat-
ments. Medical therapy with smooth muscle relaxants, including
Ca2þ channels blockers, nitrates and phosphodiesterase type 5 in-
hibitors have shown some level of efﬁcacy in ameliorating symp-
toms (2,5). The present results suggest that KATP channel openers,including nicorandil, may provide an additional pharmacological
tool for improving the spastic dysmotility of the esophagus in pa-
tients with non-cardiac chest pain. Also, our results might have
signiﬁcant clinical implications for the subset of patients using
nicorandil who do not receive full symptomatic alleviation from
gastroesophageal reﬂux disease.
In conclusion, the present study provides evidence that nicor-
andil inhibits carbachol-induced LES contraction in rats and this
was associated with activation of the KATP channel. Therapeutic
strategies that activates KATP channel may therefore represent an
additional option for the treatment of spastic esophageal motility
disorders.
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